News
The FimmCyte News
“Discover The FimmCyte Insights—your source for the latest developments, innovative ideas, and exciting projects from our company. Here, we share news, analyses, and exclusive insights that reflect our commitment and vision for the future. Stay informed and see how FimmCyte is shaping progress!”
FimmCyte Recognized in the 2024 TOP 100 Swiss Startup Award
FimmCyte proudly claims a spot in the prestigious 2024 TOP 100 Swiss Startup Award, ranking #28 overall and achieving 4th place in the biotech sector. Selected by a panel of 100 leading investors...
FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund
FimmCyte, a pioneering women's health biotech, announces an investment of 1 million CHF as a convertible loan from the UZH Life Sciences Fund (LSF). FimmCyte’s most advanced program is a...
FimmCyte Recognized in the 2024 TOP 100 Swiss Startup Award
FimmCyte proudly claims a spot in the prestigious 2024 TOP 100 Swiss Startup Award, ranking #28 overall and achieving...
FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund
FimmCyte, a pioneering women's health biotech, announces an investment of 1 million CHF as a convertible loan from the...
FimmCyte welcomes Dr. Markus Kalousek as Chairperson of the Board of Directors
FimmCyte AG, a pioneering women's health biotech, announces the appointment of Dr. Markus Kalousek as chairperson of...